Autologous Cord Blood Cell Therapy for Neonatal Encephalopathy

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

October 31, 2017

Study Completion Date

July 31, 2019

Conditions
Neonatal EncephalopathyHypoxic-ischemic Encephalopathy
Interventions
OTHER

Autologous umbilical cord blood cells

Autologous non-cryopreserved volume- and red blood cell-reduced cord blood cells will be intravenously infused

Trial Locations (6)

466-8560

Nagoya University Hospital, Nagoya

710-8602

Kurashiki Central Hospital, Kurashiki

350-0495

Saitama Medical University, Kawagoe

533-0032

Yodogawa Christian Hospital, Osaka

534-0021

Osaka City General Hospital, Osaka

545-8585

Osaka City University, Osaka

All Listed Sponsors
collaborator

Osaka City University

OTHER

collaborator

Yodogawa Christian Hospital

OTHER

collaborator

Kurashiki Central Hospital

OTHER

collaborator

Nagoya University

OTHER

collaborator

Osaka City General Hospital

OTHER

collaborator

Saitama Medical University

OTHER

collaborator

National Cerebral and Cardiovascular Center, Japan

OTHER

collaborator

National Center for Child Health and Development, Japan

UNKNOWN

collaborator

Tokyo University

OTHER

collaborator

Tokyo Women's Medical University

OTHER

lead

Neonatal Encephalopathy Consortium, Japan

NETWORK

NCT02256618 - Autologous Cord Blood Cell Therapy for Neonatal Encephalopathy | Biotech Hunter | Biotech Hunter